Patients with oligometastatic prostate cancer treated with stereotactic ablative radiotherapy had longer progression-free survival than observation-only controls
An efficient new way to account for stray radiation in radiotherapy plans allows accurate dose predictions for the whole body, promising treatments with fewer long-term side effects
With its minute sensitive volume, the new device achieves the high spatial resolution required for external and internal dosimetry in small-field radiotherapy